A cruise-ship cluster with three deaths triggered international public health response, including environmental assessments, isolation measures, and medical evacuation of symptomatic passengers for ...
For BTK inhibitor selection in frontline CLL treatment, age, risk profile, and long-term sequencing strategy influence ...
Claims-based analysis showed 64% of patients received ATTR-CM diagnosis ≥6 months after incident HF, with median delays ...
A meta-analysis of 26 trials found that IV ketamine rapidly reduced suicidal and depressive symptoms in patients with major ...
MFN pegs US net prices to the second-lowest net price in an eight-country basket, using rebate-inclusive definitions to limit list-price inflation and rebate-based circumvention. Prospective MFN for ...
Evidence suggests that adoption of oncology biosimilars in Medicare value-based payment models has produced substantial cost ...
Healthcare data’s high fraud utility and broad clinical dependencies make ransomware uniquely harmful, coupling identity ...
Katie Eyes, MSW, reflects on 25 years of the BCBSNC Foundation and, over her 18 years with the organization, its shift toward ...
Tapia, MD, PhD, discusses the results of the ADAPT OCULUS trial, which found promising results for treating patients with ...
Swedish registry follow-up of >5.3 million pre-pandemic and >5.5 million pandemic adults linked death of a partner, child, ...
Rising rates appear concentrated in hormone receptor–positive disease, aligning with later age at first birth, fewer ...
Vepdegestrant becomes the first FDA-approved heterobifunctional protein degrader (PROTAC) in breast cancer, targeting ER ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results